Dose escalation with external beam radiation therapy and high-dose-rate brachytherapy combined with long-term androgen deprivation therapy in high and very high risk prostate cancer: Comparison of two consecutive high-dose-rate schemes

Brachytherapy
Alicia OlarteRafael Martínez-Monge

Abstract

To compare rectal toxicity, urinary toxicity, and nadir+2 PSA relapse-free survival (bRFS) in two consecutive Phase II protocols of high-dose-rate (HDR) brachytherapy used at the authors institution from 2001 to 2012. Patients with National Comprehensive Cancer Network high risk and very high risk prostate cancer enrolled in studies HDR4 (2001-2007, n = 183) and HDR2 (2007-2012, n = 56) were analyzed. Patients received minipelvis external beam radiation therapy/intensity-modulated external radiotherapy to 54 Gy and 2 years of androgen blockade along with HDR brachytherapy. HDR4 protocol consisted of four 4.75 Gy fractions delivered in 48 hours; the HDR2 protocol delivered two 9.5 Gy fractions in 24 hours. Average 2-Gy equivalent dose (α/β = 1.2) prostate D90 doses for the HDR4 and HDR2 groups were 89.8 Gy and 110.5 Gy, respectively (p = 0.0001). Both groups were well balanced regarding risk factors. Prior transurethral resection of the prostate was more frequent in the HDR2 group (p = 0.001). After a median followup of 7.4 years (range, 2-11.2), there was no difference in adverse grade ≥ 2 rectal events (HDR4 = 10.4% vs. HDR2 = 12.5%; p = ns) or grade ≥3 (HDR4 = 2.2% vs. HDR2 = 3.6%; p = ns). No differences in urinary grade ≥2 ...Continue Reading

References

Jul 20, 2002·International Journal of Radiation Oncology, Biology, Physics·Alan PollackIsaac Rosen
Apr 30, 2003·Cancer radiothérapie : journal de la Société française de radiothérapie oncologique·György Kovács, Razvan Galalae
Oct 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerald E HanksUNKNOWN Radiation Therapy Oncology Group
Feb 19, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jinka R SathyaMark Levine
Mar 1, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Lennart AströmKarl Axel Johansson
Jun 7, 2005·International Journal of Radiation Oncology, Biology, Physics·Jeff M MichalskiJames D Cox
May 2, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephanie T H PeetersJoos V Lebesque
Dec 13, 2006·The Journal of Urology·Thinh P PhanFarhan Khan
Mar 4, 2008·International Journal of Radiation Oncology, Biology, Physics·Michael J ZelefskyHoward I Amols
Apr 17, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Eric M HorwitzWilliam U Shipley
Dec 15, 2010·International Journal of Radiation Oncology, Biology, Physics·Véronique BeckendorfPierre Bey
Dec 21, 2010·International Journal of Radiation Oncology, Biology, Physics·Nasiruddin MohammedAlavaro Martinez
Feb 8, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Cristiano Beck NevianiHeloisa de Andrade Carvalho
Feb 22, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Peter J HoskinLinda Bryant

❮ Previous
Next ❯

Citations

Feb 23, 2021·Brachytherapy·Kevin Martell, Marisa A Kollmeier

❮ Previous
Next ❯

Related Concepts

Related Feeds

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.